• 1
    Kremers HM, Gabriel SE. Rheumatoid arthritis and the heart. Curr Heart Fail Rep 2006; 3: 5763.
  • 2
    Quyyumi AA. Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor? Circulation 2006; 114: 11379.
  • 3
    Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 817.
  • 4
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003; 110: 13216.
  • 5
    Casado E, Gratacos J, Tolosa C, Martinez JM, Ojanguren I, Ariza A, et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2006; 65: 38590.
  • 6
    Costedoat-Chalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, et al. Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 2007; 107: 7380.
  • 7
    Keating RJ, Bhatia S, Amin S, Williams A, Sinak LJ, Edwards WD. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction. J Am Soc Echocardiogr 2005; 18: 981.
  • 8
    McAllister HA Jr, Ferrans VJ, Hall RJ, Strickman NE, Bossart MI. Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 1987; 111: 9536.
  • 9
    Baguet JP, Tremel F, Fabre M. Chloroquine cardiomyopathy with conduction disorders. Heart 1999; 81: 2213.
  • 10
    Nord JE, Shah PK, Rinaldi RZ, Weisman MH. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum 2004; 33: 33651.
  • 11
    Piette JC, Guillevin L, Chapelon C, Wechsler B, Bletry O, Godeau P. Chloroquine cardiotoxicity [letter]. N Engl J Med 1987; 317: 7101.
  • 12
    Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985; 3: 17380.
  • 13
    Hazenberg BP, van Rijswijk MH. Where has secondary amyloid gone? Ann Rheum Dis 2000; 59: 5779.
  • 14
    Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45 Suppl 4: iv47.
  • 15
    Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356: 236171.
  • 16
    Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001; 85: 32141.
  • 17
    Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila) 2006; 44: 1735.
  • 18
    Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA–positive connective tissue diseases. Arthritis Rheum 2004; 50: 124852.
  • 19
    Sokoloff L. The heart in rheumatoid arthritis. Am Heart J 1953; 45: 63543.
  • 20
    Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006; 54: 607.
  • 21
    Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 41220.
  • 22
    Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2004; 33: 2318.
  • 23
    Arslan S, Bozkurt E, Sari RA, Erol MK. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol 2006; 25: 2949.
  • 24
    Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005; 52: 303944.
  • 25
    Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, and the Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107: 313340.
  • 26
    Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004; 109: 1594602.
  • 27
    Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004; 116: 30511.
  • 28
    Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ Res 1990; 67: 75363.
  • 29
    Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, et al. Tumor necrosis factor α-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 285465.
  • 30
    Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 138291.
  • 31
    Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-α causes lethal myocarditis in transgenic mice. J Card Fail 1997; 3: 11724.
  • 32
    Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 1998; 97: 137581.
  • 33
    Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, et al. Cardiac-specific overexpression of tumor necrosis factor-α causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000; 102: 16906.
  • 34
    Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001; 104: 82631.
  • 35
    Raza K, Banks M, Kitas GD. Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. J Rheumatol 2005; 32: 7546.
  • 36
    Morris PB, Imber MJ, Heinsimer JA, Hlatky MA, Reimer KA. Rheumatoid arthritis and coronary arteritis. Am J Cardiol 1986; 57: 68990.
  • 37
    Van Albada-Kuipers GA, Bruijn JA, Westedt ML, Breedveld FC, Eulderink F. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis 1986; 45: 9635.
  • 38
    Lebowitz WB. The heart in rheumatoid arthritis (rheumatoid disease): a clinical and pathological study of sixty-two cases. Ann Intern Med 1963; 58: 10223.
  • 39
    Cruickshank B. Heart lesions in rheumatoid disease. J Pathol Bacteriol 1958; 76: 22340.
  • 40
    Evrengul H, Dursunoglu D, Cobankara V, Polat B, Seleci D, Kabukcu S, et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004; 24: 198202.
  • 41
    Stojanovich L, Milovanovich B, de Luka SR, Popovich-Kuzmanovich D, Bisenich V, Djukanovich B, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren's syndrome and other autoimmune diseases. Lupus 2007; 16: 1815.
  • 42
    Parnes EI, Krasnosel'skii MI, Tsurko VV, Striuk RI. Long-term prognosis in patients with rheumatoid arthritis depending on baseline variability of cardiac rhythm. Ter Arkh 2005; 77: 7780. In Russian.
  • 43
    Seferovic PM, Ristic AD, Maksimovic R, Simeunovic DS, Ristic GG, Radovanovic G, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006; 45 Suppl 4: iv3942.
  • 44
    Goldeli O, Dursun E, Komsuoglu B. Dispersion of ventricular repolarization: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. J Rheumatol 1998; 25: 44750.
  • 45
    Cindas A, Gokce-Kutsal Y, Tokgozoglu L, Karanfil A. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 2002; 31: 226.
  • 46
    Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol 1998; 17: 36977.
  • 47
    Wislowska M, Sypula S, Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 1999; 18: 1639.
  • 48
    Ahern M, Lever JV, Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983; 42: 38997.
  • 49
    Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD. Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 1988; 63: 13746.
  • 50
    Mutru O, Laakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989; 76: 717.
  • 51
    Sigal LH, Friedman HD. Rheumatoid pancarditis in a patient with well controlled rheumatoid arthritis. J Rheumatol 1989; 16: 36873.
  • 52
    Bonfiglio T, Atwater EC. Heart disease in patients with seropositive rheumatoid arthritis: a controlled autopsy study and review. Arch Intern Med 1969; 124: 7149.
  • 53
    Khan AH, Spodick DH. Rheumatoid heart disease. Semin Arthritis Rheum 1972; 1: 32737.
  • 54
    Hardouin P, Thevenon A, Beuscart R, Tison-Muchery F, Duquesnoy B, Thery C, et al. Evaluation of cardiac involvement in advanced rheumatoid arthritis: clinical, electrocardiographic, echographic and gallium and thallium double scintigraphic study of 28 patients. Rev Rhum Mal Osteoartic 1988; 55: 6837. In French.
  • 55
    Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994; 21: 336.